Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: the multi-ethnic study of atherosclerosis (MESA). Flueckiger, P., Qureshi, W., Michos, E. D., Blaha, M., Burke, G., Sandfort, V., Herrington, D., & Yeboah, J. Clinical Cardiology, Wiley Online Library, nov, 2016.
Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: the multi-ethnic study of atherosclerosis (MESA) [link]Paper  doi  bibtex   
@Article{Flueckiger_2016_17307,
  author = {Flueckiger, Peter and Qureshi, Waqas and Michos, Erin D. and Blaha, Michael and Burke, Gregory and Sandfort, Veit and Herrington, David and Yeboah, Joseph},
 journal = {Clinical Cardiology},
 month = {nov},
 pages = {1-7},
 publisher = {Wiley Online Library},
 title = {Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: the multi-ethnic study of atherosclerosis (MESA)},
 year = {2016},
 issn = {1932-8737},
 url = {http:https://dx.doi.org/10.1002/clc.22642},
 doi = {10.1002/clc.22642},
 title_with_no_special_chars = {Guidelinebased statinlipidlowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events The MultiEthnic Study of Atherosclerosis MESA}
}
Downloads: 0